Next Article in Journal
Changes in Lifestyle and Dietary Habits during COVID-19 Lockdown in Italy: Results of an Online Survey
Previous Article in Journal
Vitamin A Status Improvement in Obesity: Findings and Perspectives Using Encapsulation Techniques
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 13
Issue 6
10.3390/nu13061922
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Oligomeric Formulas in Surgery: A Delphi and Consensus Study

by
Daniel De Luis Román
1,
Eduardo Domínguez Medina
2,
Begoña Molina Baena
3 and
Pilar Matía-Martín
4,*
1
Center of Investigation Endocrinology and Nutrition, Hospital Clínico Universitario de Valladolid, Medicine School University, 47002 Valladolid, Spain
2
Center for Research in Molecular Medicine and Chronic Diseases (CiMUS), 15782 Santiago de Compostela, Spain
3
Hospital Universitario de la Princesa, 28006 Madrid, Spain
4
Endocrinology and Nutrition Unit, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain
*
Author to whom correspondence should be addressed.
Nutrients 2021, 13(6), 1922; https://doi.org/10.3390/nu13061922
Submission received: 1 May 2021 / Revised: 28 May 2021 / Accepted: 29 May 2021 / Published: 3 June 2021
(This article belongs to the Section Clinical Nutrition)
Review Reports Versions Notes

Abstract

:
Nutritional management of patients with intestinal failure often includes the use of oligomeric formulas. Implementing the use of oligomeric formulas in surgical patients with maldigestion or malabsorption could be a nutritional strategy to be included in clinical protocols. We aim to generate knowledge from a survey focused on the effectiveness of nutritional therapy with oligomeric formulas with Delphi methodology. Each statement that reached an agreement consensus among participants was defined as a median consensus score ≥7 and as an interquartile range ≤3. The use of oligomeric formulas in surgical patients, starting enteral nutrition in the post-operative phase in short bowel syndrome and in nonspecific diarrhea after surgical procedures, could improve nutritional therapy implementation. Stakeholders agreed that early jejunal enteral nutrition with oligomeric formula is more effective compared to intravenous fluid therapy and it is useful in patients undergoing upper gastro-intestinal tract major surgery when malabsorption or maldigestion is suspected. Finally, oligomeric formulas may be useful when a feeding tube is placed distally to the duodenum. This study shows a practical approach to the use of oligomeric formulas in surgical patients with intestinal disorders and malabsorption, and it helps clinicians in the decision-making process.

1. Introduction

Evidence obtained from observational data generated during routine clinical practice or Real-World Data (RWD) is an important source for supporting clinical decisions about nutritional interventions. Although physicians could take advantage of RWD for their informed decisions, data are not always accessible or clinically relevant [1].
Intestinal failure (IF)—the reduction of gut function below the minimum necessary for the absorption of macronutrients and/or water and electrolytes, such that intravenous supplementation is required to maintain health and/or growth—and intestinal insufficiency (II)—the reduction of gut absorptive function that does not require intravenous supplementation to maintain health and/or growth [2]—are severe medical conditions intimately related, among others, to short bowel syndrome (SBS), which is a malabsorption disorder caused by a lack of functional small intestine, resulting in an inadequate fluid and nutrient absorption [3].
The origin of malnutrition in intestinal diseases is multifactorial and includes a deficient intake of nutrients, maldigestion and malabsorption due to different clinical conditions, with surgery being one of the most involved etiologies in these clinical situations. These alterations usually cause abdominal discomfort, diarrhea, weight loss and malnutrition. Thus, prevention and correction of nutritional deficit with the assessment of nutritional status is critical and should be part of the multidisciplinary management of these patients [4].
Polymeric enteral nutrition (EN) is the most used formula for enteral nutritional support; however, EN with oligomeric formulas containing peptides and medium chain triglycerides (MCT) is part of the management of patients with intestinal diseases and IF or II, including SBS [5,6], and can facilitate the absorption of nutrients in case of impaired intestinal function or anatomical change after surgery [7,8]. The use and implementation of clinical protocols for nutritional treatment of IF or II may facilitate the standardization of care and decision-making with regards to the use of oligomeric formulas in these patients.
The European Society for Clinical Nutrition and Metabolism (ESPEN) has established “special interest groups” devoted to developing guidelines for the formal definition and classification of IF [9,10]. These recommendations are relevant to approach decision-making situations in the clinical management of these patients.
The combination of data information and clinical experience is the standard procedure to demonstrate the effectiveness of specific interventions, such as the use of oligomeric formulas, nutrition monitoring and surveillance and the assessment of metabolic status.
The aim of this study is to support an evidence-based decision-making process of oligomeric formulas in patients with intestinal disorders after surgery in the context of a surgeon’s experience.

2. Materials and Methods

This study was carried out by using the Delphi method. In Spain, this study does not require Research Ethics Committees (RECs) approval or written consent from patients.
We elaborated a prospective consensus study using a Delphi process. Delphi is a structured process effective to evaluate the cost, effectiveness, applicability and sustainability in a medical setting and it is widely used in developing core outcomes sets. The Delphi method aims to achieve consensus through the collection of stakeholder opinions and is especially useful in those clinical situations in which there is great uncertainty due to a lack of information or consensus [11].

2.1. Phase 1

A coordinating group was set up to inform the development of the various stages of this study and to discuss the results at each phase. The coordinating group, formed by endocrinologists with a strong background in clinical nutrition, raised, defined and justified existing controversies about the use of oligomeric formulas in intestinal diseases. To develop a preliminary list of assessments for a Delphi survey, stakeholders performed a literature review about the prescription of oligomeric diets in patients with intestinal diseases and existing controversies in clinical practice.

2.2. Phase 2

The coordinating group prepared a document with 13 clinical questions focused on the use of oligomeric formulas in patients that had undergone digestive surgery for intestinal diseases, including clinical conditions such as hyper-secretion phase in SBS, postoperative upper digestive tract, nonspecific diarrhea, gastrectomy, pancreaticoduodenectomy, fistulas and colon resection.

2.3. Phase 3

The study was carried out with the participation of 47 surgeons with extensive experience in digestive surgery and nutrition, from 35 different Spanish hospitals (see Acknowledgments). Each of the participants engaged voluntarily in the study and their answers were coded to keep them anonymous and confidential.
A document explaining the project and survey was sent out to participants, and the Delphi survey consisted of two consecutive rounds. In round 1, a document explaining the purpose of the study, the Delphi method and how to complete the survey was sent to the panelists. All participants were asked to score each assessment and to identify any additional important assessment that did not appear in the list. To evaluate the pertinence to the survey, the coordinating group reviewed additional assessments added in round 1.
The first round remained open for 6 weeks with a 4-week reminder sent to those surgeons that had partially completed or not completed the questionnaire. At the end of the first round, after 6 weeks, all participants completed the survey and their answers were coded and anonymized in a database.

2.4. Phase 4

In round 2, the results from round 1 were analyzed. Following the analysis, the results were reviewed by the coordinating group and considered comparable in terms of percentage spread across the responses of 1–9. Assessments without consensus were revised and rephrase in a dichotomic way (Yes/No).

2.5. Scoring Method

In each round, panelists were asked to indicate their level of agreement with each statement using a nine-point scale (1: “strongly disagree” to 9: “strongly agree”). Scores 1–3 (rank 1) were considered as having a low degree of agreement, implementation, or knowledge according to the question, scores 4–6 (rank 2) were considered as doubtful and scores 7–9 (rank 3) were considered as having a high degree of agreement.

2.6. Methods of Analysis

For each round, descriptive statistics were used to summarize the results for each question, including the percentage of participants scoring from 1 to 9. Each statement that achieved an agreement consensus was defined as a median consensus score (MED) of ≥7, and as an interquartile range (IQR) of ≤3. Likewise, a MED score of ≤3 was considered as a consensus to refuse the statement, while an IQR of ≥4 or a MED of 4–6 was considered as no agreement. Those statements were reviewed and included in the second round with only two possible answers (Yes/No) and we considered general consensus when 50% or more of the answer were “Yes” or “No”.

2.7. Data Analysis

Statistical analysis was performed with the statistical software IBM-SPSS version 23 (Chicago, IL, USA). MED, IQR and Standard Deviation were calculated for each statement. A comparison of variables was performed with a non-parametric U-Mann Whitney test and a p-value < 0.05 was regarded as significant.

3. Results

3.1. Participant Characteristics

A total of 47 panelists completed the survey (76.6% men). Most worked in a General and Digestive Surgery Unit (66%) and had an assistant position (63.8%). Furthermore, most surgeons (37%) worked in medium-large hospitals with 500–1000 hospital beds (Table 1).

3.2. Descriptive Statistics

The descriptive statistics of the 13 statements and the following consensus among the experts are shown in Table 2.
Globally, the survey showed a lack of knowledge about ESPEN recommendations [9] by most of the surgeons (MED 3, with 53.2% of answers in rank 1 score 1–3). The degree of application of this article among the surgeons surveyed was also low (MED 3, with cumulative percentage in rank 1 in 55.3% of them).
We found a high application of ESPEN clinical guidelines with regards to the use of a small number of oligomeric formulas as an option to start enteral or oral nutrition in the post-operative hyper-secretion phase in SBS in the case of gastrointestinal intolerance of polymeric formulas (with 80.9% of the surgeons consulted (n = 38) scoring 7 or higher—MED 8).
Most of the experts (68.1%) agreed that oligomeric low-fat formulas could be used in patients with nonspecific diarrhea (MED 7), while only 6.4% disagreed.
Surgeons reached a positive consensus (MED 7) with regard to the use of oligomeric formulas in patients undergoing gastrectomy, especially with a Roux-en-Y anastomosis and maldigestion. We found that 72.4% (n = 34) of surgeons awarded a score of 7 or more, while only 4.3% (n = 2) disagreed.
A positive consensus was achieved regarding the usefulness of oligomeric formulas in patients treated with cephalic pancreaticoduodenectomy with maldigestion, with 76.6% (n = 36) of experts awarding a score of 7 or more (MED 8), and also in patients with low-debit ileus or colon fistulas, with 89.4% of surgeons (n = 52) awarding a score of 7 or higher (MED 8). Furthermore, most experts (72.3%, n = 34) agreed (MED 8) that oligomeric formulas are well tolerated in patients treated with right hemicolectomy or total colectomy.
Surgeons surveyed did not reach a consensus in the first round about the statement “ESPEN guidelines recommend the use of needle catheter jejunostomy (NCJ) in patients undergoing major upper gastrointestinal and pancreatic surgery,” with 19 physicians (40.5%) giving a score of 3 or less and 19 (40.5%) giving a score of 7 or higher. In order to reach a consensus, the same question was asked again in a dichotomous way (yes/no), and a consensus of no agreement was reached by simple majority (53.2%, n = 25 versus 46.8%, n = 22) in the second round.
Likewise, participants did not reach a consensus in the first round regarding the statement “In clinical practice, it is common to place a feeding tube distally to the anastomosis in the surgical act,” with 36.2% (n = 17) giving a score of 3 or less and 31.9% (n = 15) giving a score of 7 or higher. In the second round, the same question was asked again but with only two possible answers (yes/no). A consensus of “no agreement” was reached by simple majority (55.3%, n = 26 versus 44.7%, n = 21).
In total, 80.9% of the experts (n = 38) agreed (MED 8) that after upper digestive tract surgery, oligomeric formula may be useful when EN is carried out distally to the duodenum and malabsorption or malnutrition are suspected.
We also found a positive consensus concerning early jejunal EN with oligomeric formulas providing more nutrients with less weight loss compared to intravenous fluid therapy (85.1%, n = 40 scored 7 or higher with MED 9) and is useful in patients undergoing upper gastro-intestinal tract major surgery (82.9%, n = 39, agreed with MED 8).

3.3. Stratified Analysis

3.3.1. Analysis According to the Existence of a Specialized Nutrition Unit

We correspondingly perform a descriptive analysis according to whether the hospital had a specialized Nutrition Unit or not (Table 3), and in all the explored items, no significant differences were detected among the answers (p = 0.113).

3.3.2. Analysis According to the Existence of a Clinical Protocol to Approach the Diagnosis and Intervention of Patients with SBS

Table 4 shows the descriptive statistics according to the existence of a clinical protocol to approach diagnosis and intervention of patients with SBS. Stratifying the hospitals, according to the existence (n = 13) or not (n = 33) of a clinical protocol, a significant difference was observed between centers with a protocol for SBS and those that did not only for question 2 (p < 0.001). In those centers with clinical protocols, we observed a high degree of agreement (MED 7), with 77% of experts scoring 7 or higher.

4. Discussion

Conclusive results to support the implementation of clinical protocols is often difficult to achieve in real-world settings. The purpose of this study was to reach a consensus that would lay the basis for the use of oligomeric formula in the management of this population of surgical patients using the Delphi method. We surveyed the knowledge on relevant consensus recommendations as well as the clinical use of oligomeric formulas in intestinal diseases associated with IF, II or intestinal surgery.
Polymeric enteral formula contains whole proteins, needing gastro-intestinal tract digestion while oligomeric formula contains hydrolyzed proteins, known as oligopeptides. These peptides have a different uptake transport mechanism that allows an improvement of intestinal absorption compared to whole proteins. Therefore, the use of oligomeric formulas in patients with intestinal surgery should be considered in clinical protocols.
We noticed an unexpected lack of knowledge of ESPEN recommendations [9] by most surgeons surveyed. This ESPEN article aims to give a formal definition and recommendations for the classification of both acute and chronic IF to simplify the collaboration and multidisciplinary management between professionals in clinical practice. It is also important to note that only 13 centers had clinical protocols for SBS, although they were applied at a high degree.
In this survey, surgeons commonly accepted the use of oligomeric EN when polymeric formulas are not tolerated in the postoperative phase of SBS, according to published guidelines [6]. Another narrative review [3] stated that high-output stomas may benefit when elemental diets are chosen, but doubt exists regarding the effect that polymeric or oligomeric formula have on intestinal adaptation after surgery. In animal models, the signs of mucosal regeneration (DNA content in the cells, length of villi and crypt depth) were more evident in polymeric formula fed animals [15], but in patients with high output jejunostomy, an improvement in the absorption of nitrogen was observed after oligomeric diet, without differences in energy or fat absorption [16]. The evidence is poor and, although more trials are needed, the experienced surgeons agree with this statement in clinical practice.
A positive consensus regarding the use of oligomeric formula was reached in nonspecific diarrhea. It has been stated that in persistent diarrhea, suggesting maldigestion or malabsorption, the oligomeric formulas with low fat content and high proportion of medium chain fatty acids can be used [12,17]. The rationale of this recommendation was based in experience and in physiological knowledge, but recently, a preliminary randomized clinical trial showed that in critical patients, including those after surgery, the use of peptide-based formulas was associated with fewer gastrointestinal events when they were compared with standard polymeric formulas [18].
Moreover, the surveyed surgeons accepted the use of oligomeric diets after gastrectomy or pancreaticoduodenectomy when maldigestion is suspected. Although there are no specific recommendations in the ESPEN guidelines devoted to surgery [14] or pancreaticoduodenectomy [19], it is a common practice to prescribe oligomeric formulas in this situation, even if the oral route is chosen and the usual diet is not sufficient to reach the protein and energy demands of the patient.
The surgeons also agreed to consider oligomeric formulas in low-debit ileus or colon fistulas. There is no expert consensus regarding the use of semi-elemental formulas when EN is chosen as the medical nutrition therapy in these situations, but data reported in some clinical cases show that this election is a usual practice in enterocutaneous fistula [20,21]. Moreover, interest is growing related to the delivery of nutrients to the distal intestinal limb when a high output proximal enterocutaneous fistula develops. This nutrition strategy, named fistuloclysis, takes advantage of the distal intestine for the infusion of nutrients and chyle drained by the upper intestine. Clinical guidelines, such as the American Society for Parenteral and Enteral Nutrition (ASPEN), recommend using polymeric formulas first and to change to oligomeric formulas if there is intolerance [22]. As they are partially digested, it is supposed that there is a higher nutrient absorption in this intestinal tract. This recommendation is based on case series reporting the advantage of fistuloclysis and EN with the election of semi-elemental formulas in patients suffering from this complication [23,24].
There was agreement in the good tolerance of oligomeric formulas in right colectomy or total colectomy. There is a paucity of published reports dealing with EN and semi-elemental formulas in this clinical condition. Diarrhea, due to a fast bowel transit time, is one of the most common complication in the early phase after total of right colectomies and affects up to 46% of patients [25,26]. Usual treatments include dietary changes, antiperistalsis drugs and cholestyramine in the right colectomy with persistence of the distal colon. Therefore, in clinical practice, oligomeric formulas are used in malnourished patients when diarrhea persists, as it has been stated in this survey, and in the experience of the surveyed surgeons, they are well tolerated. We only found one study comparing polymeric formulas with or without fibers after laparoscopic colectomy [27], and more patients had formed stool in the group assigned to the formula with fiber. Thus, more research is needed in this area. Two studies have evaluated the role of elemental formulas (containing complete digested proteins) in the recovery after colectomy and in colorectal surgery complicated with anastomotic leakage. Both studies had, as comparator, treatment with parenteral nutrition. The first one reported a diminished estimated minimum length of stay (LOS) for the recovery associated to the prescription of the elemental formula [13], and in the second situation, the duration of parenteral nutrition was shorter when the elemental formula was used after this complication [28]. To our knowledge, there are no studies evaluating semi-elemental formulas under these circumstances.
The surgeons did not agree on the placement of a feeding tube during the surgical act, usually a needle catheter jejunostomy distal to the anastomosis. ESPEN guidelines devoted to clinical nutrition in surgery advise to consider this strategy in malnourished patients submitted to major upper gastrointestinal surgery or pancreatectomy [14], but in those regarding Enhanced Recovery After Surgery (ERAS) in pancreaticoduodenectomy, the recommendation is to feed with a tube only when an early oral diet has failed, and do not consider systematically to place a jejunostomy [19]. Indeed, controversy exists among surgeons related to this topic. Different studies have shown the feasibility and advantages of EN using a feeding tube distal to the anastomosis, with the tip passed distally in the surgical act. However, there is no consensus about the routine use of a needle catheter jejunostomy, and some authors consider it only for high-risk patients [29]. A recent paper described that more than 8000 patients that had undergone esophagectomy presented with lower LOS, in-hospital mortality and 30-day mortality in the 45% concurrent surgical jejunostomies, compared with no tube placement during surgery [30]. On the other hand, one study using propensity score matching (139 per group) reported a higher incidence of bowel obstruction in patients with jejunostomy tube feeding, while there was no difference in the nutritional status between groups [31]. After gastrectomy, more incidence of complications has been related to jejunostomy, calling individualization to attention [29,32], and in pancreatic surgery, the routine use of distal EN has been abandoned [33,34]. Thus, this is an area of uncertainty, where individualization and the type of intervention required (gastrectomy, esophagectomy or pancreatectomy) may lead to different outcomes after the placement of a jejunostomy. However, the surgeons agreed on the usefulness of early jejunal EN with oligomeric formula in patients undergoing upper gastrointestinal surgery. This is of importance in undernourished patients not meeting oral requirements after surgery [14].
The election of oligomeric formulas when EN is provided distally to the anastomosis after upper gastrointestinal surgery is currently practiced among the surveyed surgeons, even though the ESPEN guidelines about surgery state that it is possible to feed the patients with a polymeric standard formula in this situation [14]. There is a lack of evidence about this topic, and in addition to the physiological mechanisms regarding absorption of nutrients when duodenum has been bypassed, novel potential advantages have been published. Thereby, the infusion of EN through jejunostomy using elemental diets with low fat content and MCT has been associated to a non-significant reduction in the incidence of chyle leak after esophagectomy [35]. Some authors advocate the use of low-fat formulas with MCT in jejunal EN after pancreatic surgery in patients at high risk of developing chyle leak and call for more research on this topic [36].
The panelists also reached a positive consensus regarding the effectiveness of early jejunal EN compared to intravenous fluid therapy. This agreement is in line with ESPEN clinical guidelines in surgical patients, which state that, whenever possible, oral or EN should be preferred [14]. Scientific evidence from the medical literature shows that an oligo-elemental diet is non-inferior to parenteral or amino acid-based diets regarding digestion, nutrient absorption and tolerance in nutritionally risk patients with Crohn’s disease, SBS and acute and chronic pancreatitis [37].
There are some limitations in this study. Participants were from Spain and represented views and clinical practices within the country. It would be relevant to explore opinions from international expert participants regarding EN in surgical patients with intestinal diseases. Another limitation was the lack of clinical protocols about SBS in most centers, which makes it difficult to homogenize the clinical practice in different hospitals. Finally, a bigger sample of panelists would have been desirable. However, the multicenter consensus reached is potentially applicable for helping the decision-making process in the clinical practice.

5. Conclusions

Our study reports a practical approach to the use of oligomeric enteral formulas in surgical patients with intestinal disorders and impaired nutrient digestion or absorption. Our results could help clinicians and surgeons in the decision-making process, to reduce heterogeneity in clinical practice. Further studies and randomized clinical trials are needed to evaluate the use of oligomeric formulas in surgical patients with intestinal diseases.

Author Contributions

Conceptualization, D.D.L.R., B.M.B. and P.M.-M.; Formal analysis, E.D.M.; Methodology, D.D.L.R., E.D.M., B.M.B. and P.M.-M.; Supervision, D.D.L.R., B.M.B. and P.M.-M.; Writing—original draft, D.D.L.R., B.M.B. and P.M.-M.; Writing—review and editing, D.D.L.R., E.D.M., B.M.B. and P.M.-M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Fresenius Kabi.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to ethical reasons.

Acknowledgments

The following investigators participated in the acquisition data of the study (multi-author group): Jose Carlos Rodríguez Pino (Hospital Son Espases), Jose Antonio Carmona Sáez (Hospital Ntra. Sra. Sonsoles), Javier Chuquiure (Policlínica Juaneda), Luis Sabater Ortí (Hospital Clínico Valencia), Segundo Gómez Abril (Hospital Doctor Peset), Julio Vaile Muñoz (Hospital Vírgen de la Salud), Omar Abdel-lah Fernández (Complejo Asistencial Universitario de Salamanca), Felipe Carlos Porreño Monchado (Complejo Asistencial Universitario de Salamanca), Ana Obispo Entrenas (Hospital Costa del Sol), Norberto Góndora Adón (Hospital Costa del Sol), Rodolfo González Sendra (Complejo Hospitalario de Jaén), Antonio Minguillón Serrano (Hospital Obispo Polanco), Alberto José Pagán Pomar (Hospital Universitario Son Espases), Sebastián Fernández Arias (Hospital Vital Álvarez Builla), Pedro Antonio Pacheco (Hospital Infanta Elena), Carlos García Vázquez (Hospital Infanta Elena), Ana Belén Álvarez Chillarón (Hospital Vírgen Altagracia), Mohamed Fadel Mojjar (Hospital Santa Bárbara), Francisco Martín Vieira (Hospital Vírgen Altagracia), Andrés Frangi (Hospital de Sagunto), Carmelo Loinaz Segurola (Hospital 12 de Octubre), Federico Ochando Cerdán (Hospital Fundación Alcorcón), Jaime Ruiz-Tovar Polo (Hospital Rey Juan Carlos), Eva Mª Fernández-Marcote Menor (Hospital Universitario Leganés), Luis Mª Flores Garnica (Hospital de Hellín), Nieves Pérez Climent (Hospital Vírgen de Los Lirios), Felisa Díaz Gómez (Hospital General de Almansa), Antonio Palomeque Jiménez (Complejo Hospitalario Universitario de Granada), Jose Antonio Santidrian Martínez (Hospital Universitario de Cruces), Íñigo López de Cemarruzabeitia (Hospital Clínico Universitario de Valladolid), Beatriz De Andrés Asenjo (Hospital Clínico Universitario de Valladolid), Rocío Ferrer Sotelo (Hospital Royo Vilanova), Ignacio Goded Broto (Hospital San Jorge), Pablo Del Pozo Gil de Paresa (Hospital de la Vega), Francisco Esteban Collazo (Hospital Clínico San Carlos), Elena Larraz Mora (Hospital El Escorial), Diego Osorio Fernández (Hospital Universitario Virgen de la Victoria), Gerardo Blanco Fernández (Hospital Infanta Cristina), Cristina Roque Castellano (Hospital Universitario Doctor Negrín), Mª Asunción Acosta Mérida (Hospital Universitario Doctor Negrín), Aida Cristina Rahy Martín (Hospital Universitario Doctor Negrín), Javier Ortiz Lacorzana (Hospital Universitario de Basurto), José Aguilar Luque (Hospital de Valme), Jose Luis Dominguez Tristancho (Hospital de Mérida), Miguel Bongera García (Hospital Vital Álvarez Buylla), Antonio Vizcaino López (Hospital San Pedro), Jose M. Muñoz de Nova (Hospital La Princesa).

Conflicts of Interest

P.M.-M. has received speaker’s fees and has worked on research projects from Fresenius Kabi, Abbott Nutrition, Nutricia, Nestlé HealthScience, Grifols, Vegenat, Adventia, Baxter, Cantabria Labs España and NovoNodisk outside the submitted work. B. Molina Baena has received speaker’s fees and has worked on research projects from Fresenius Kabi, Abbott Nutrition, Nutricia, Nestlé HealthScience, Vegenat, Lilly and NovoNodisk outside the submitted work. D.D.L.R. has received speaker’s fees and has worked on research projects from Fresenius Kabi, Abbott Nutrition, Nutricia, Nestlé HealthScience, Grifols, Vegenat, Adventia, Cantabria Labs España, Lilly and NovoNodisk outside the submitted work. The funders had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Galbraith, K.; Ward, A.; Heneghan, C. A real-world approach to Evidence-Based Medicine in general practice: A competency framework derived from a systematic review and Delphi process. BMC Med. Educ. 2017, 17, 78. [Google Scholar] [CrossRef] [Green Version]
  2. Kappus, M.; Diamond, S.; Hurt, R.T.; Martindale, R. Intestinal Failure: New Definition and Clinical Implications. Curr. Gastroenterol. Rep. 2016, 18. [Google Scholar] [CrossRef]
  3. Carroll, R.E.; Benedetti, E.; Schowalter, J.P.; Buchman, A.L. Management and Complications of Short Bowel Syndrome: An Updated Review. Curr. Gastroenterol. Rep. 2016, 18, 1–13. [Google Scholar] [CrossRef] [PubMed]
  4. Williams, D.G.; Molinger, J.; Wischmeyer, P.E. The malnourished surgery patient. Curr. Opin. Anaesthesiol. 2019, 32, 405–411. [Google Scholar] [CrossRef] [PubMed]
  5. Bharadwaj, S.; Tandon, P.; Meka, K.; Rivas, J.M.; Jevenn, A.; Kuo, N.-T.; Steiger, E. Intestinal Failure. J. Clin. Gastroenterol. 2016, 50, 366–372. [Google Scholar] [CrossRef]
  6. Klek, S.; Forbes, A.; Gabe, S.; Holst, M.; Wanten, G.; Irtun, Ø; Damink, S.O.; Panisic-Sekeljic, M.; Pelaez, R.B.; Pironi, L.; et al. Management of acute intestinal failure: A position paper from the European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group. Clin. Nutr. 2016, 35, 1209–1218. [Google Scholar] [CrossRef] [PubMed]
  7. Ohkura, Y.; Ueno, M.; Shindoh, J.; Iizuka, T.; Udagawa, H. Randomized controlled trial on efficacy of oligomeric formula (HINE E-GEL®) versus polymeric formula (MEIN®) enteral nutrition after esophagectomy for esophageal cancer with gastric tube reconstruction. Dis. Esophagus 2019, 32. [Google Scholar] [CrossRef] [PubMed]
  8. Cederholm, T.; Barazzoni, R.; Austin, P.; Ballmer, P.; Biolo, G.; Bischoff, S.C.; Compher, C.; Correia, I.; Higashiguchi, T.; Holst, M.; et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin. Nutr. 2017, 36, 49–64. [Google Scholar] [CrossRef] [PubMed]
  9. Pironi, L.; Arends, J.; Baxter, J.; Bozzetti, F.; Peláez, R.B.; Cuerda, C.; Forbes, A.; Gabe, S.; Gillanders, L.; Holst, M.; et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin. Nutr. 2015, 34, 171–180. [Google Scholar] [CrossRef]
  10. Pironi, L.; Corcos, O.; Forbes, A.; Holst, M.; Joly, F.; Jonkers, C.; Klek, S.; Lal, S.; Blaser, A.R.; Rollins, K.E.; et al. Intestinal failure in adults: Recommendations from the ESPEN expert groups. Clin. Nutr. 2018, 37, 1798–1809. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Humphrey-Murto, S.; Varpio, L.; Wood, T.J.; Gonsalves, C.; Ufholz, L.A.; Mascioli, K.; Wang, C.; Foth, T. The Use of the Delphi and Other Consensus Group Methods in Medical Education Research: A Review. Acad Med. 2017, 92, 1491–1498. [Google Scholar] [CrossRef]
  12. McClave, S.A.; Rd, B.E.T.; Martindale, R.G.; Rd, M.M.W.; Johnson, D.R.; Rd, C.B.; Rn, M.S.M.; Davanos, E.; Rice, T.W.; Rd, G.A.C.; et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient. J. Parenter. Enter. Nutr. 2015, 40, 159–211. [Google Scholar] [CrossRef] [PubMed]
  13. Shichinohe, T.; Sasaki, T.; Kitashiro, S.; Morita, T.; Ono, K.; Senmaru, N.; Ikeda, J.; Kojima, T.; Kyogoku, N.; Yamada, H.; et al. Impact of elemental diet on early recovery after laparoscopic colectomy: Findings of a randomized controlled trial. Surg. Today 2016, 47, 166–173. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Weimann, A.; Braga, M.; Carli, F.; Higashiguchi, T.; Hübner, M.; Klek, S.; Laviano, A.; Ljungqvist, O.; Lobo, D.N.; Martindale, R.; et al. ESPEN guideline: Clinical nutrition in surgery. Clin. Nutr. 2017, 36, 623–650. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Lai, H.-S.; Chen, W.J.; Chen, K.M.; Lee, Y.N. Effects of monomeric and polymeric diets on small intestine following massive resection. Taiwan yi xue hui za zhi. J. Formos. Med. Assoc. 1989, 88, 982–988. [Google Scholar]
  16. Cosnes, J.; Evard, D.; Beaugerie, L.; Gendre, J.P.; Le Quintrec, Y. Improvement in protein absorption with a small-peptide-based diet in patients with high jejunostomy. Nutrition 1992, 8, 1486247. [Google Scholar]
  17. De Brito-Ashurst, I.; Preiser, J.-C. Diarrhea in Critically Ill Patients. J. Parenter. Enter. Nutr. 2016, 40, 913–923. [Google Scholar] [CrossRef]
  18. Seres, D.S.; Ippolito, P.R. Pilot study evaluating the efficacy, tolerance and safety of a peptide-based enteral formula versus a high protein enteral formula in multiple ICU settings (medical, surgical, cardiothoracic). Clin. Nutr. 2017, 36, 706–709. [Google Scholar] [CrossRef] [PubMed]
  19. Lassen, K.; Coolsen, M.M.; Slim, K.; Carli, F.; de Aguilar-Nascimento, J.E.; Schäfer, M.; Parks, R.W.; Fearon, K.C.; Lobo, D.N.; Demartines, N.; et al. Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. Clin. Nutr. 2012, 31, 817–830. [Google Scholar] [CrossRef]
  20. Kucharski, M.A.; Wierzbicka, A.; Tsibulski, A.; Sotiri, E.; Dobrowolska, A.; Mańkowska-Wierzbicka, D. Parenteral and Enteral Nutrition: A Bridge to Healing and Biological Therapy in a Patient With Enterocutaneous Fistula and Sepsis Complicated Crohn’s Disease. J. Parenter. Enter. Nutr. 2021, 45, 430–433. [Google Scholar] [CrossRef]
  21. Xie, C.; Lin, J.; Su, J.; Ren, J. Synergistic effect of enteral nutrition on remission induction in a patient with penetrating Crohn disease. Medicine 2019, 98, e16750. [Google Scholar] [CrossRef]
  22. Kumpf, V.J.; De Aguilar-Nascimento, J.E.; Graf, J.I.D.-P.; Hall, A.M.; McKeever, L.; Steiger, E.; Winkler, M.F.; Compher, C.W.; FELANPE, American Society for Parenteral and Enteral Nutrition. ASPEN-FELANPE Clinical Guidelines. J. Parenter. Enter. Nutr. 2017, 41, 104–112. [Google Scholar] [CrossRef]
  23. Teubner, A.; Morrison, K.; Ravishankar, H.R.; Anderson, I.D.; Scott, N.A.; Carlson, G.L. Fistuloclysis can successfully replace parenteral feeding in the nutritional support of patients with enterocutaneous fistula. BJS 2004, 91, 625–631. [Google Scholar] [CrossRef]
  24. Wu, Y.; Ren, J.; Wang, G.; Zhou, B.; Ding, C.; Gu, G.; Chen, J.; Liu, S.; Li, J. Fistuloclysis Improves Liver Function and Nutritional Status in Patients with High-Output Upper Enteric Fistula. Gastroenterol. Res. Pr. 2014, 2014, 1–10. [Google Scholar] [CrossRef] [PubMed]
  25. Schoeters, P.; De Pooter, K. Lanreotide Autogel in the Treatment of Persistent Diarrhea following a Total Colectomy. Case Rep. Gastrointest. Med. 2015, 2015, 1–5. [Google Scholar] [CrossRef] [Green Version]
  26. Zutshi, M.; Hull, T.L.; Trzcinski, R.; Arvelakis, A.; Xu, M. Surgery for slow transit constipation: Are we helping patients? Int. J. Color. Dis. 2007, 22, 265–269. [Google Scholar] [CrossRef] [PubMed]
  27. Zhao, M.L.; Xue, Q.; Li, Y.N.; Wang, Y.N.; Chen, T.; Zhao, L.Y. Clinical observation of early oral enteral nutrition after laparo-scopic colectomy. Zhonghua Wei Chang Wai Ke Za Zhi 2013, 16, 1041–1044. [Google Scholar] [PubMed]
  28. Ishibe, A.; Ota, M.; Kanazawa, A.; Watanabe, J.; Tatsumi, K.; Watanabe, K.; Godai, T.; Yamagishi, S.; Fujii, S.; Ichikawa, Y.; et al. Nutritional management of anastomotic leakage after colorectal cancer surgery using elemental diet jelly. Hepatogastroenterology 2015, 62, 30–33. [Google Scholar]
  29. Dann, G.C.; Squires, M.H.; Postlewait, L.M.; Kooby, D.A.; Poultsides, G.A.; Weber, S.M.; Bloomston, M.; Fields, R.C.; Pawlik, T.M.; Votanopoulos, K.I.; et al. An assessment of feeding jejunostomy tube placement at the time of resection for gastric adenocarcinoma: A seven-institution analysis of 837 patients from the U.S. gastric cancer collaborative. J. Surg. Oncol. 2015, 112, 195–202. [Google Scholar] [CrossRef] [PubMed]
  30. Watson, M.; Trufan, S.; Benbow, J.H.; Gower, N.L.; Hill, J.; Salo, J.C. Jejunostomy at the time of esophagectomy is associated with improved short-term perioperative outcomes: Analysis of the NSQIP database. J. Gastrointest. Oncol. 2020, 11, 421–430. [Google Scholar] [CrossRef]
  31. Koterazawa, Y.; Oshikiri, T.; Hasegawa, H.; Yamamoto, M.; Kanaji, S.; Yamashita, K.; Matsuda, T.; Nakamura, T.; Suzuki, S.; Kakeji, Y. Routine placement of feeding jejunostomy tube during esophagectomy increases postoperative complications and does not improve postoperative malnutrition. Dis. Esophagus 2019, 33. [Google Scholar] [CrossRef]
  32. Choi, A.H.; O’Leary, M.P.; Merchant, S.J.; Sun, V.; Chao, J.; Raz, D.J.; Kim, J.Y.; Kim, J. Complications of Feeding Jejunostomy Tubes in Patients with Gastroesophageal Cancer. J. Gastrointest. Surg. 2017, 21, 259–265. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Gerritsen, A.; Besselink, M.G.H.; Gouma, D.J.; Steenhagen, E.; Rinkes, I.H.M.B.; Molenaar, I.Q. Systematic review of five feeding routes after pancreatoduodenectomy. BJS 2013, 100, 589–598. [Google Scholar] [CrossRef]
  34. Waliye, H.E.; Wright, G.P.; McCarthy, C.; Johnson, J.; Scales, A.; Wolf, A.; Chung, M. Utility of feeding jejunostomy tubes in pancreaticoduodenectomy. Am. J. Surg. 2017, 213, 530–533. [Google Scholar] [CrossRef]
  35. Moro, K.; Koyama, Y.; Kosugi, S.-I.; Ishikawa, T.; Ichikawa, H.; Hanyu, T.; Miura, K.; Nagahashi, M.; Nakajima, M.; Tatsuda, K.; et al. Low fat-containing elemental formula is effective for postoperative recovery and potentially useful for preventing chyle leak during postoperative early enteral nutrition after esophagectomy. Clin. Nutr. 2016, 35, 1423–1428. [Google Scholar] [CrossRef] [Green Version]
  36. Abu Hilal, M.; Layfield, D.M.; Di Fabio, F.; Arregui-Fresneda, I.; Panagiotopoulou, I.G.; Armstrong, T.H.; Pearce, N.W.; Johnson, C.D. Postoperative Chyle Leak After Major Pancreatic Resections in Patients Who Receive Enteral Feed: Risk Factors and Management Options. World J. Surg. 2013, 37, 2918–2926. [Google Scholar] [CrossRef] [PubMed]
  37. Sanz-Paris, A.; Martinez-García, M.; Martinez-Trufero, J.; Lambea-Sorrosal, J.; Calvo-Gracia, F.; López-Alaminos, M.E. Oligomeric Enteral Nutrition in Undernutrition, due to Oncology Treatment-Related Diarrhea. Systematic Review and Proposal of An Algorithm of Action. Nutrition 2019, 11, 1888. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Table
Table 1. Characteristics of the Delphi panelists and their healthcare facilities.
Table 1. Characteristics of the Delphi panelists and their healthcare facilities.
General Participant Characteristics N (%)
GenderFemales11 (23.4%)
Males36 (76.6%)
Surgery UnitMetabolic and Bariatric1 (2.1%)
Colorectal3 (6.4%)
Esophagogastric5 (10.6%)
General and Digestive31 (66%)
General and Endocrine1 (2.1%)
Hepatobiliary and Pancreatic6 (12.8%)
Clinical PositionAssistant30 (63.8%)
Section Chief13 (27.7%)
Head of Service4 (8.5%)
Number of hospital beds<1001 (2.2%)
100–25011 (23.9%)
250–50015 (32.6%)
500–1000 17 (37%)
>1000 2 (4.3%)
Nutrition UnitNo14 (29.8%)
Yes33 (70.2%)
Nutritional protocols for SBSNo34 (72.3%)
Yes13 (27.7%)
SBS: Short bowel syndrome.
Table
Table 2. Statements with the descriptive statistics and the consensus among the participants.
Table 2. Statements with the descriptive statistics and the consensus among the participants.
StatementFrequencyMedianIQRConsensus (YES/NO)
Question 1ACan you assess your knowledge about the article “Pironi L et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015; 34(2):171–80” [9].4733YES
Question 1BCan you assess the degree of application in your clinical practice of this article “Pironi L et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015; 34(2):171-80” [9].4633YES
Question 2Rate the degree of application in your clinical practice of the SBS protocol used in your center (if applicable).4633YES
Question 3ESPEN clinical guidelines state that a small amount of peptide-based EN is an option to start enteral or oral nutrition in the post-operative hyper-secretion phase of SBS in patients that cannot tolerate polymeric formulas [6].4681YES
Question 4Oligomeric low-fat formulas are effective for patients with nonspecific diarrhea [12].4672YES
Question 5In patients undergoing gastrectomy, especially with a Roux-en-Y anastomosis, oligomeric formula can be beneficial when maldigestion is suspected.4672YES
Question 6Oligomeric formulas can be beneficial in patients treated with cephalic pancreaticoduodenectomy with maldigestion.4681YES
Question 7Oligomeric formulas can be beneficial in patients with low-debit ileus or colon fistulas.4682YES
Question 8Oligomeric formulas are well tolerated in patients treated with right hemicolectomy or total colectomy [13].4682YES
Question 9ESPEN guidelines recommend the use of needle catheter jejunostomy (NCJ) in patients undergoing major abdominal surgery [14].4655NO *
Question 10In clinical practice, it is common to place a feeding tube distally to the anastomosis in the surgical act.4645NO *
Question 11In patients with suspected malabsorption/maldigestion, after upper digestive tract surgery, oligomeric formulas may be useful when EN is carried out distally to the duodenum.4681YES
Question 12Early jejunal EN with oligomeric formulas provide more nutrients with less weight loss compared to intravenous fluid therapy.4691YES
Question 13In patients with suspected malabsorption/maldigestion, early jejunal EN with oligomeric formulas is useful in patients undergoing major upper gastro-intestinal tract surgery.4682YES
* This question was asked again in a dichotomous way (yes/no) to reach an agreement in the second round. EN: enteral nutrition; SBS: Short Bowel Syndrome IQR: interquartile range.
Table
Table 3. Statements with descriptive statistics according to the existence of a Nutrition Unit in the Hospital.
Table 3. Statements with descriptive statistics according to the existence of a Nutrition Unit in the Hospital.
Hospitals with Nutrition Unit Hospitals without Nutrition Unit
FrequencyMedianIQRFrequencyMedianIQR
Question 1A14363236
Question 1B14353234
Question 214113236
Question 314823271
Question 414723271
Question 514723282
Question 614713282
Question 714823282
Question 814823282
Question 914453254
Question 1014353255
Question 1114823282
Question 1214813291
Question 1314813282
IQR; Interquartile range.
Table
Table 4. Descriptive statistics according to the existence of a clinical protocol to approach the diagnosis and intervention of patients with SBS.
Table 4. Descriptive statistics according to the existence of a clinical protocol to approach the diagnosis and intervention of patients with SBS.
Hospitals Without Nutritional Support Protocols in SBSHospitals with Nutritional Support Protocols in SBS
FrequencyMedianIQRFrequencyMedianIQR
Question 1A33361345
Question 1B33351343
Question 233111373
Question 333821371
Question 433721371
Question 533721372
Question 633811372
Question 733821381
Question 833821381
Question 933551344
Question 1033451324
Question 1133821381
Question 1233911381
Question 1333811382
IQR; Interquartile range.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

De Luis Román, D.; Domínguez Medina, E.; Molina Baena, B.; Matía-Martín, P. Oligomeric Formulas in Surgery: A Delphi and Consensus Study. Nutrients 2021, 13, 1922. https://doi.org/10.3390/nu13061922

AMA Style

De Luis Román D, Domínguez Medina E, Molina Baena B, Matía-Martín P. Oligomeric Formulas in Surgery: A Delphi and Consensus Study. Nutrients. 2021; 13(6):1922. https://doi.org/10.3390/nu13061922

Chicago/Turabian Style

De Luis Román, Daniel, Eduardo Domínguez Medina, Begoña Molina Baena, and Pilar Matía-Martín. 2021. "Oligomeric Formulas in Surgery: A Delphi and Consensus Study" Nutrients 13, no. 6: 1922. https://doi.org/10.3390/nu13061922

APA Style

De Luis Román, D., Domínguez Medina, E., Molina Baena, B., & Matía-Martín, P. (2021). Oligomeric Formulas in Surgery: A Delphi and Consensus Study. Nutrients, 13(6), 1922. https://doi.org/10.3390/nu13061922

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop